Medicare plans praise Novo Nordisk, AstraZeneca, and Janssen/J&J for their contracting and value-added resources. When contracting and resource ratings are combined, Novo Nordisk is #1, followed by Janssen/J&J in 2nd place and AstraZeneca in 3rd.

To learn more, please download the free research highlights above.